haloperidol has been researched along with Coma, Hyperglycemic Hyperosmolar Nonketotic in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 50-year-old man presented with hyperosmolar non-ketotic diabetic coma associated with the neuroleptic malignant syndrome (NMS) after intramuscular treatment with haloperidol." | 3.68 | Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma. ( Balzan, M; Cacciottolo, JM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, MF | 1 |
| Carvalho Neto, EG | 1 |
| Kowacs, F | 1 |
| Rieder, CRM | 1 |
| Balzan, M | 1 |
| Cacciottolo, JM | 1 |
2 other studies available for haloperidol and Coma, Hyperglycemic Hyperosmolar Nonketotic
| Article | Year |
|---|---|
Non-ketotic hyperosmolar hyperglycemic chorea.
Topics: Aged, 80 and over; Anti-Dyskinesia Agents; Chorea; Haloperidol; Humans; Hyperglycemic Hyperosmolar N | 2019 |
Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma.
Topics: Body Temperature Regulation; Combined Modality Therapy; Depressive Disorder; Diagnosis, Differential | 1992 |